Testing for SARS-CoV-2 Portuguese Experience: Clinical, Ethical andEconomical Perspectives

Abstract

Portugal, unlike its neighbors, Spain and Italy, has so far managed to maintain the flattening of the epidemiological curve of Infections by SARS-CoV 2. The pandemic response strategy in this country included the implementation of measures commonly referred to as non-pharmacological, as well as the rapid growth of responsiveness to perform RTPCR tests for the diagnosis of COVID-19. The clinical and epidemiological reflection of the measures adopted political and economic considerations, is made, and ends with a bioethical analysis of the methodologies implemented.